Impact of exposure to malaria and nutritional status on responses to the experimental malaria vaccine ChAd63 MVA ME-TRAP in 5-17 month-old children in Burkina Faso
<p>The experimental malaria vaccine ChAd63 MVA ME-TRAP previously showed protective efficacy against Plasmodium falciparum infection in Phase IIa sporozoite challenge studies in adults in the United Kingdom and in a Phase IIb field efficacy trial in Kenyan adults. However, it failed to demonst...
Автори: | Morter, R, Tiono, AB, Nébié, I, Hague, O, Ewer, K, Sirima, SB |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
Frontiers Media
2022
|
Схожі ресурси
Схожі ресурси
-
Impact of exposure to malaria and nutritional status on responses to the experimental malaria vaccine ChAd63 MVA ME-TRAP in 5-17 month-old children in Burkina Faso
за авторством: Richard Morter, та інші
Опубліковано: (2022-12-01) -
First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children
за авторством: Tiono, AB, та інші
Опубліковано: (2018) -
First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children.
за авторством: Alfred B Tiono, та інші
Опубліковано: (2018-01-01) -
Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African children and infants
за авторством: Bliss, C, та інші
Опубліковано: (2016) -
Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations.
за авторством: Kimani, D, та інші
Опубліковано: (2014)